<DOC>
	<DOCNO>NCT02897180</DOCNO>
	<brief_summary>The use supplement food like `` Nyaditum resae '' reliable opportunity stop progression towards active TB update knowledge disease : induction tolerance . In order demonstrate percentage efficacy approach , different study must run elucidate percentage protection different setting world . The strategy establish efficacy simple clinical trial , aim know incidence TB Placebo NR treat contact active TB case .</brief_summary>
	<brief_title>Efficacy Nyaditum Resae ( R ) Against Active TB Georgia</brief_title>
	<detailed_description>Evaluation supplement food `` Nyaditum resae '' uincidence TB . This ranzomized doube-blind control clinical trial evaluate efficacy safety supplememt food comparison placebo TB .</detailed_description>
	<mesh_term>Tuberculosis</mesh_term>
	<criteria>1 . Have complete write informed consent process prior undergo screen evaluation . 2 . Have ability complete followup period require protocol . 3 . Willing allow investigator discuss subject 's medical history subject 's health care provider . 4 . Close contact active TB case eligible chemoprophylaxis . 1 . Investigator assessment lack understand willingness participate comply requirement trial protocol . 2 . Any finding opinion investigator would compromise protocol compliance significantly influence interpretation result effect vaccine . 3 . Being eligible chemoprophylaxis ( child &lt; 5 year old HIVpositive adult ) 4 . Pregnancy lactation 5 . Hypersensitivity mannitol 6 . Suffering active TB</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>tuberculosis</keyword>
	<keyword>latent tuberculosis infection</keyword>
	<keyword>Food supplement</keyword>
	<keyword>Mycobacterium manresensis</keyword>
	<keyword>Nyaditum resae</keyword>
	<keyword>Efficacy trial</keyword>
</DOC>